We are live on ! Find out more
ZIVO

Zivo Bioscience, Inc. Common Stock
ZIVO

Delisted

ZIVO was delisted on the 24th of November, 2023.

Back to rankings

2 hedge funds and large institutions have $60.4K invested in Zivo Bioscience, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CA
CoreCap Advisors
Michigan
+$58.9K
2
HNB
Huntington National Bank
Ohio
+$1.55K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
1
CoreCap Advisors
Michigan
$58.9K +$58.9K +4,360 New
HNB
2
Huntington National Bank
Ohio
$1.55K +$1.55K +104 New

ZIVO Hedge Fund Activity: Q2 2025 in Review

2 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q2 2025, worth a combined $60.4K.

Buyers outnumbered sellers: 2 funds opened new ZIVO positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was CoreCap Advisors, opening a new position worth an estimated $58.9K.

  • 2 institutional investors held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q2 2025, up from 0 in Q1 2025.
  • Funds reported $60.4K of Zivo Bioscience, Inc. Common Stock stock for Q2 2025.
  • 2 funds opened new Zivo Bioscience, Inc. Common Stock positions in Q2 2025 and 0 closed out, a net change of +2 holders.
  • The largest Zivo Bioscience, Inc. Common Stock buyer in Q2 2025 was CoreCap Advisors, an estimated $58.9K added.

Based on aggregated 13F filings for Q2 2025.